Post-Transplant and In-Hospital Risk Factors for ARDS After Hematopoietic Stem Cell Transplantation

被引:3
|
作者
Herasevich, Svetlana [1 ]
Frank, Ryan [2 ]
Hogan, William J. [3 ]
Alkhateeb, Hassan [3 ]
Limper, Andrew H. [4 ]
Gajic, Ognjen [4 ]
Yadav, Hemang [4 ,5 ]
机构
[1] Mayo Clin, Dept Anesthesiol & Perioperat Med, Rochester, MN USA
[2] Mayo Clin, Div Hlth Sci Res Biomed Stat & Informat, Rochester, MN USA
[3] Mayo Clin, Div Hematol, Rochester, MN USA
[4] Mayo Clin, Div Pulm & Crit Care Med, Rochester, MN USA
[5] Mayo Clin, Div Pulm & Crit Care Med, 200 1st St SW, Rochester, MN 55905 USA
关键词
ARDS; bone marrow trans- plant; hematopoietic stem cell transplantation; respiratory failure; ICU; immunocompromised host; RESPIRATORY-DISTRESS-SYNDROME; INJURY PREDICTION SCORE; PULMONARY COMPLICATIONS; EPIDEMIOLOGY; MORTALITY; OUTCOMES;
D O I
10.4187/respcare.10224
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
BACKGROUND: ARDS is a serious complication of hematopoietic stem cell transplant (HSCT). Pre-transplant risk factors for developing ARDS after HSCT have been recently identified. The objective of this study was to better understand post-transplant risk factors for developing ARDS after HSCT. METHODS: This was a nested case-control study. ARDS cases were matched to hospitalized non-ARDS controls by age, type of transplantation (allogeneic vs autologous), and time from transplantation. In a conditional logistic regression model, any potential risk factors were adjusted a priori for risk factors known to be associated with ARDS development. RESULTS: One hundred and seventy ARDS cases were matched 1:1 to non-ARDS hospitalized controls. Pre-admission, cases were more likely to be on steroids (odds ratio [OR] 1.90 [1.13- 3.19], P = .02). At time of admission, cases had lower platelet count (OR 0.95 [0.91-0.99], P = .02), lower bicarbonate (OR 0.94 [0.88-0.99], P = .035), and higher creatinine (OR 1.91 [1.23- 2.94], P = .004). During the first 24 h after admission, cases were more likely to have received transfusion (OR 2.41 [1.48-3.94], P < .001), opioids (OR 2.94 [1.67-5.18], P < .001), and have greater fluid administration (OR 1.52 [1.30-1.78], P < .001). During the hospitalization, ARDS cases had higher temperature (OR 1.77 [1.34-2.33], P < .001) and higher breathing frequency (OR 1.52 [1.33-1.74], P < .001). ARDS cases were more likely to have had sepsis (OR 68.0 [15.2- 301.7], P < .001), bloodstream infection (OR 4.59 [2.46-8.57], P < .001), and pneumonia (OR 9.76 [5.01-19.00], P < .001). CONCLUSIONS: Several post-transplant predictors of ARDS development specific to the HSCT population were identified in the pre-hospital and early in-hospital domains. These findings can provide insights into causal mechanisms of ARDS development and be used to develop HSCT-specific risk prediction models.
引用
收藏
页码:77 / 86
页数:10
相关论文
共 50 条
  • [1] Risk Factors and Predictive Scoring System For Post-Transplant Lymphoproliferative Disorder after Hematopoietic Stem Cell Transplantation
    Fujimoto, Ayumi
    Hiramoto, Nobuhiro
    Yamasaki, Satoshi
    Inamoto, Yoshihiro
    Uchida, Naoyuki
    Maeda, Tetsuo
    Mori, Takehiko
    Kande, Yoshinobu
    Kondo, Tadakazu
    Shiratori, Souichi
    Miyakoshi, Shigesaburo
    Ishiyama, Ken
    Ikegame, Kazuhiro
    Matsuhashi, Yoshiko
    Tanaka, Junji
    Ichinohe, Tatsuo
    Atsuta, Yoshiko
    Ogata, Masao
    Suzuki, Ritsuro
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (07) : 1441 - 1449
  • [2] Monomorphic Post-transplant Lymphoproliferative Disorder After Kidney Transplantation and Hematopoietic Stem Cell Transplantation: Clinicopathological Characteristics, Treatments and Prognostic Factors
    Fu, Li
    Xie, Jianlan
    Lin, Jun
    Wang, Jingshi
    Wei, Na
    Huang, Dayong
    Wang, Tingting
    Shen, Jing
    Zhou, Xiaoge
    Wang, Zhao
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2017, 33 (04) : 492 - 499
  • [3] Risk Factors for the Incidence of and the Mortality due to Post-Transplant Lymphoproliferative Disorder after Hematopoietic Cell Transplantation
    Kinzel, Megan
    Dowhan, Michelle
    Kalra, Amit
    Williamson, Tyler S.
    Dabas, Rosy
    Jamani, Kareem
    Chaudhry, Ahsan
    Shafey, Mona
    Jimenez-Zepeda, Victor
    Duggan, Peter
    Daly, Andrew
    Dharmani-Khan, Poonam
    Khan, Faisal
    Storek, Jan
    TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (01): : 53.e1 - 53.e10
  • [4] Post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantation
    Romero, Samuel
    Montoro, Juan
    Guinot, Marta
    Almenar, Luis
    Andreu, Rafael
    Balaguer, Aitana
    Beneyto, Isabel
    Espi, Jordi
    Gomez-Codina, Jose
    Iacoboni, Gloria
    Jarque, Isidro
    Lopez-Andujar, Rafael
    Mayordomo-Aranda, Empar
    Montalar, Joaquin
    Pastor, Amparo
    Pastor, Miguel
    Pinana, Jose L.
    Rojas-Ferrer, Nohelia
    Sanchez-Lazaro, Ignacio
    Sandoval, Jesus
    Sanz, Guillermo
    Sanz, Miguel A.
    Sole, Amparo
    Sanz, Jaime
    LEUKEMIA & LYMPHOMA, 2019, 60 (01) : 142 - 150
  • [5] Pretransplant Risk Factors Can Predict Development of Acute Respiratory Distress Syndrome after Hematopoietic Stem Cell Transplantation
    Herasevich, Svetlana
    Frank, Ryan D.
    Bo, Hong
    Alkhateeb, Hassan
    Hogan, William J.
    Gajic, Ognjen
    Yadav, Hemang
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2021, 18 (06) : 1004 - 1012
  • [6] Prognostic Factors and Intensive Care Outcome in Post-Transplant Phase of Hematopoietic Stem Cell Transplantation Intensive Care Outcome in Hematopoietic Stem Cell Transplantation
    Mutlu, Yasa Gul
    Aydin, Berrin Balik
    Erdogan, Cem
    Kizilaslan, Deniz
    Bekoz, Huseyin Saffet
    Gemici, Aliihsan
    Kaynar, Leylagul
    Sevindik, Omur Gokmen
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2023, 39 (02) : 167 - 172
  • [7] Monomorphic Post-transplant Lymphoproliferative Disorder After Kidney Transplantation and Hematopoietic Stem Cell Transplantation: Clinicopathological Characteristics, Treatments and Prognostic Factors
    Li Fu
    Jianlan Xie
    Jun Lin
    Jingshi Wang
    Na Wei
    Dayong Huang
    Tingting Wang
    Jing Shen
    Xiaoge Zhou
    Zhao Wang
    Indian Journal of Hematology and Blood Transfusion, 2017, 33 : 492 - 499
  • [8] Comparative analysis of post-transplant lymphoproliferative disorder after kidney transplantation versus hematopoietic stem cell transplantation
    Yoon, Jae-Ho
    Lee, Seok
    Kim, Hee-Je
    Lee, Jong-Wook
    Min, Woo-Sung
    Chung, Byung Ha
    Yang, Chul Woo
    Kim, Yong-Soo
    Kim, Ji-Il
    Moon, In Sung
    Oh, Eun Ji
    Park, Gyeong-Sin
    Cho, Seok-Goo
    TRANSPLANT INTERNATIONAL, 2014, 27 (07) : 721 - 732
  • [9] Prognostic Factors and Intensive Care Outcome in Post-Transplant Phase of Hematopoietic Stem Cell TransplantationIntensive Care Outcome in Hematopoietic Stem Cell Transplantation
    Yaşa Gül Mutlu
    Berrin Balik Aydin
    Cem Erdogan
    Deniz Kizilaslan
    Hüseyin Saffet Beköz
    Aliihsan Gemici
    Leylagül Kaynar
    Ömür Gökmen Sevindik
    Indian Journal of Hematology and Blood Transfusion, 2023, 39 : 167 - 172